- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02123589
The Psychological Effects of Different Sedation Protocol on Mechanically Ventilated Critically Ill Adults.
April 23, 2014 updated by: Kangyan, West China Hospital
The Psychological Effects of Different Sedation Protocol on Mechanically Ventilated Critically Ill adults-a Prospective, Randomized and Controlled Trial
The study was designed to explore the effects of different sedation protocol on incidence rates of delirium and PTSD in severe patients with mechanically ventilation.
Study Overview
Status
Unknown
Conditions
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Phase 4
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Written informed consent
- Critically ill adults whose expected time of mechanical ventilation is longer than 24 hours
- Aged between 18 years old to 85 years old.
Exclusion Criteria:
- Subjects with brain injury;
- History of cardiopulmonary resuscitation;
- Mental disability;
- Taken neuromuscular blocking drugs;
- Inability to exchange;
- Contraindicated to midazolam or morphine;
- Inconvenience to daily interruption
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Deep sedation
Injection of 0.05~0.1mg/kg
midazolam and 1~2μg/kg fentanyl,then continuous intravenous infusion 0.05mg/kg.h
midazolam and1~2μg/kg.h
fentanyl to maintain sedation until attaining the target level of sedation,RASS score between -5 and -3
|
0.05~0.1mg/kg
midazolam and 1~2μg/kg fentanyl,IV; 0.05mg/kg.h
midazolam and1~2μg/kg.h
fentanyl,continuous intravenous infusion ; the target level of sedation,RASS score between -5 and -3
|
|
Experimental: Deep and daily interruption of sedation
Injection of 0.05~0.1mg/kg
midazolam and 1~2μg/kg fentanyl,then continuous intravenous infusion 0.05mg/kg.h
midazolam and1~2μg/kg.h
fentanyl to maintain sedation until attaining the target level of sedation,RASS score between -5 and -3.and from the second day after subject was admitted in ICU, daily interruption of sedation will be taken .
|
0.05~0.1mg/kg
midazolam and 1~2μg/kg fentanyl,IV; 0.05mg/kg.h
midazolam and1~2μg/kg.h
fentanyl continuous intravenous infusion ; The target level of sedation,RASS score between -5 and -3.
Daily interruption of sedation will be taken from the second day after admitted in ICU
|
|
Experimental: Light sedation
Injection of 0.05~0.1mg/kg
midazolam and 1~2μg/kg fentanyl,then continuous intravenous infusion 0.05mg/kg.h
midazolam and1~2μg/kg.h
fentanyl to maintain sedation until attaining the target level of sedation,RASS score between -2 and +1.
|
0.05~0.1mg/kg
midazolam and 1~2μg/kg fentanyl,IV; 0.05mg/kg.h
midazolam and1~2μg/kg.h
fentanyl,continuous intravenous infusion ; The target level of sedation,RASS score between -2 and +1;
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The incident rate of delirium
Time Frame: From weaning to discharged from ICU,about 7 days.
|
From weaning to discharged from ICU,about 7 days.
|
|
The incident rates of PTSD
Time Frame: 30th day and 180th day after discharged from ICU
|
30th day and 180th day after discharged from ICU
|
|
The duration of delirium
Time Frame: From weaning to discharged from ICU,about 7 days.
|
From weaning to discharged from ICU,about 7 days.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence rate of unexpected extubation
Time Frame: From intubation to weaning,about 7 days
|
From intubation to weaning,about 7 days
|
|
Dosage of analgesics and sedatives
Time Frame: From intination of analgesics and sedatives to stopping drug appication,about 7 days
|
From intination of analgesics and sedatives to stopping drug appication,about 7 days
|
|
The duration of mechanical ventilation
Time Frame: From intubation to weaning,about 7days
|
From intubation to weaning,about 7days
|
|
Duration of ICU
Time Frame: From admitted to ICU to discharged from ICU,about 7 days
|
From admitted to ICU to discharged from ICU,about 7 days
|
|
The whole hospitalization time
Time Frame: From admitted to hospital to discharged from hospital,about 7 days
|
From admitted to hospital to discharged from hospital,about 7 days
|
|
Patients' death rates within ICU stay
Time Frame: From admitted to ICU to discharged from ICU,about 7 days
|
From admitted to ICU to discharged from ICU,about 7 days
|
|
Patients' death rates within hospitalized stay
Time Frame: From admitted to hospital to discharged from hospital,about 7 days
|
From admitted to hospital to discharged from hospital,about 7 days
|
|
The cost in ICU
Time Frame: From admitted to ICU to discharged from ICU,about 7 days
|
From admitted to ICU to discharged from ICU,about 7 days
|
|
The total cost in hospital
Time Frame: From admitted to hospital to discharged from hospital,about 7 days
|
From admitted to hospital to discharged from hospital,about 7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2014
Primary Completion (Anticipated)
May 1, 2015
Study Completion (Anticipated)
December 1, 2015
Study Registration Dates
First Submitted
April 22, 2014
First Submitted That Met QC Criteria
April 23, 2014
First Posted (Estimate)
April 25, 2014
Study Record Updates
Last Update Posted (Estimate)
April 25, 2014
Last Update Submitted That Met QC Criteria
April 23, 2014
Last Verified
April 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Pathologic Processes
- Nervous System Diseases
- Neurologic Manifestations
- Confusion
- Neurobehavioral Manifestations
- Neurocognitive Disorders
- Disease Attributes
- Delirium
- Critical Illness
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Tranquilizing Agents
- Psychotropic Drugs
- Hypnotics and Sedatives
- Adjuvants, Anesthesia
- Anti-Anxiety Agents
- GABA Modulators
- GABA Agents
- Fentanyl
- Midazolam
Other Study ID Numbers
- West ChinaH Sedation
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sedative Withdrawal Delirium
-
Children's National Research InstituteCompletedNoise Exposure | Sedative Toxicity | Sedative Withdrawal DeliriumUnited States
-
Peking UniversityRecruitingAirway Control | Sedative, Hypnotic, or Anxiolytic WithdrawalChina
-
Denver Health and Hospital AuthorityTerminatedAlcohol Withdrawal Delirium | Alcohol Withdrawal Associated Autonomic Hyperactivity | Alcohol Withdrawal Hallucinosis | Alcohol Withdrawal-Induced Delirium TremensUnited States
-
Beijing Chao Yang HospitalNot yet recruitingAnesthesia Awareness | Remimazolam | Sedative, Hypnotic, or Anxiolytic Withdrawal
-
Jubilee Mission Medical College and Research InstituteINCRE fellowship from DBT, govt of IndiaCompletedAlcohol Withdrawal Symptoms | Delirium Tremens (DTs)
-
KK Women's and Children's HospitalCompletedAnesthesia | Sedation Complication | Anesthesia; Adverse Effect | Sedative Adverse Reaction | Anesthesia Emergence DeliriumSingapore
-
OSF Healthcare SystemUnknownAlcohol Withdrawal | Alcohol Withdrawal DeliriumUnited States
-
Unity Health TorontoTerminatedAlcohol Withdrawal | Alcohol Withdrawal Delirium | Alcohol Withdrawal SeizuresCanada
-
Hospital Italiano de Buenos AiresActive, not recruitingDelirium | Sedative OverdoseArgentina
-
Asan Medical CenterCompleted
Clinical Trials on Deep sedation(midazolam and fentanyl )
-
Humanitas Clinical and Research CenterNot yet recruiting
-
Helsinki University Central HospitalRecruitingFever | Blood Pressure | Acute Kidney Failure | Temperature | Cardiac Arrest (CA) | Out of Hospital Cardiac Arrest | Sedation in Intensive Care Unit Patients | Mean Arterial Pressure Targets | Sedation in the ICU | Resuscitated Sudden Cardiac Death | Renal Replacement Therapy for Acute Kidney Injury in ICU | Sedation in Intensive CareSweden, Norway, Australia, Finland, United Kingdom, New Zealand, Switzerland, Belgium, Estonia, Singapore, Germany, Saudi Arabia, Luxembourg, Italy
-
Benha UniversityNot yet recruiting
-
Southeast University, ChinaCompleted
-
MemorialCare Health SystemMemorial Medical Center FoundationCompleted
-
Gødstrup HospitalUniversity of AarhusNot yet recruitingAtrial Flutter | Atrial Fibrillation (AF)Denmark
-
Suez UniversityNot yet recruiting
-
Meir Medical CenterCompletedMechanically Ventilated PatientsIsrael
-
University of OklahomaWithdrawn
-
Beijing Anzhen HospitalCompletedAtrial Fibrillation (AF) | Deep Sedation | PFAChina